LivaNova PLC (LIVN)
NASDAQ: LIVN · Real-Time Price · USD
78.01
+0.22 (0.28%)
At close: Sep 18, 2026, 4:00 PM EDT
78.01
0.00 (0.00%)
After-hours: Sep 18, 2026, 7:30 PM EDT
LivaNova Market Cap
LivaNova has a market cap or net worth of $4.3 billion as of September 18, 2026. Its market cap has increased by 44.35% in one year.
Market Cap
4.30B
Enterprise Value
4.13B
1-Year Change
44.35%
Ranking
Category
Stock Price
$78.01
ChartMarket Cap Chart
Since October 19, 2015, LivaNova's market cap has increased from $3.42B to $4.30B, an increase of 25.84%. That is a compound annual growth rate of 2.13%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 18, 2026 | 4.30B | 27.91% |
| Dec 31, 2025 | 3.36B | 33.61% |
| Dec 31, 2024 | 2.51B | -9.78% |
| Dec 29, 2023 | 2.79B | -6.24% |
| Dec 30, 2022 | 2.97B | -36.12% |
| Dec 31, 2021 | 4.65B | 44.63% |
| Dec 31, 2020 | 3.22B | -11.87% |
| Dec 31, 2019 | 3.65B | -18.02% |
| Dec 31, 2018 | 4.45B | 15.57% |
| Dec 29, 2017 | 3.85B | 75.67% |
| Dec 30, 2016 | 2.19B | -24.35% |
| Dec 31, 2015 | 2.90B | -15.10% |
| Oct 19, 2015 | 3.42B | - |
View and export this data all the way back to 2015. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haemonetics | 4.90B |
| Integer Holdings | 4.29B |
| iRhythm Holdings | 3.68B |
| TransMedics Group | 3.00B |
| Neogen | 2.80B |
| Axogen | 2.66B |
| Alamar Biosciences | 2.22B |
| UFP Technologies | 2.13B |